辐照血液成分的临床应用研究

Study the Clinical Application of Irradiated Red Blood Cell Components

目的:探讨分析辐照血液成分的临床用量及所占比例。方法:统计分析青岛地区2010-2014年辐照血液成分的临床用血量及占总用血量的比例,对比分析近几年辐照血液成分比例变化。结果:青岛地区近5年临床用血量中辐照红细胞类成分占红细胞类总用血量的0.91%,辐照血小板类占血小板总用量的7.40%。与前两年相比,近3年辐照血液成分占总用血量的比例大幅增加。结论:随着对TA-GVHD认识的进一步深入,临床对辐照血液成分的重视程度加大,辐照血液成分的使用量也不断增加。

Objective：To analyze the clinical application and the proportion of irradiated red blood cell components.Method： The clinical application in irradiation blood components of Qingdao from 2010 to 2014 were statistical analyzed,the irradiated blood composition changes in recent years were compared and analyzed.Result：Nearly the five years, the percentage of irradiated red blood cells in the total clinical usage was 0.91%,and the percentage of irradiated aphaeresis platelet in the total clinical usage was 7.40%. Compared with the previous two years, a big increasion in the clinical usage of irradiated red blood cell components in the nearly three years.Conclusion：Along with the further understanding of TA-GVHD,clinical doctors pay more attention to the application in irradiation blood components and the use of irradiation blood components also increased.